William K Heiden's Net Worth
$11.8 Million
Who is William K Heiden?
William K Heiden has an estimated net worth of $11.8 Million. This is based on reported shares across multiple companies, which include Atara Biotherapeutics, Inc., AMAG PHARMACEUTICALS INC., MACROGENICS INC, GTC BIOTHERAPEUTICS INC, and PRAECIS PHARMACEUTICALS INC.
SEC CIK
William K Heiden's CIK is 0001214939
Past Insider Trading and Trends
2017 was William K Heiden's most active year for acquiring shares with 7 total transactions. William K Heiden's most active month to acquire stocks was the month of April. 2015 was William K Heiden's most active year for disposing of shares, totalling 13 transactions. William K Heiden's most active month to dispose stocks was the month of January. 2015 saw William K Heiden paying a total of $1,039,200.00 for 245,500 shares, this is the most they've acquired in one year. In 2015 William K Heiden cashed out on 128,727 shares for a total of $7,538,098.42, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Atara Biotherapeutics, Inc. (ATRA) Snapshot price: $9.1465
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +71.77% | 150K |
—
|
—
| 359K |
Mar 31
| |||
Form 4
| +91.74% | 100K |
$0.25 | $25,330.00 | 209K |
Nov 10
| |||
Form 4
| +109.62% | 57K |
—
|
—
| 109K |
May 31
| |||
Form 4
| +65.08% | 20.5K |
—
|
—
| 52K |
Jun 23
| |||
Form 4
| +53.66% | 11K |
—
|
—
| 31.5K |
Jun 8
| |||
Form 4
| +64.00% | 8K |
—
|
—
| 20.5K |
Jun 16
| |||
Form 4
| +47.06% | 4K |
—
|
—
| 12.5K |
Jun 27
| |||
Form 4
| +21.43% | 1.5K |
—
|
—
| 8.5K |
Jun 14
| |||
Form 4
| +250.00% | 5K |
—
|
—
| 7K |
Jun 8
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMAG PHARMACEUTICALS, INC. No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.04% | -4.45K |
$7.75 | -$34,495.25 | 424.61K |
Mar 2
| |||
Form 4
| -1.22% | -5.99K |
$9.17 | -$54,931.72 | 484.06K |
Feb 23 - Feb 25
| |||
Form 4
| +2.08% | 10K |
$10.70 | $107,000.00 | 490.06K |
May 9
| |||
Form 4
| -1.64% | -8.00K |
$14.76 | -$118,109.52 | 480.06K |
Mar 1 - Mar 2
| |||
Form 4
| +50.14% | 163K |
—
|
—
| 488.06K |
Feb 25
| |||
Form 4
| -0.90% | -2.96K |
$15.51 | -$45,863.07 | 325.06K |
Feb 23
| |||
Form 4
| -1.50% | -5.00K |
$25.00 | -$125,000.00 | 328.01K |
Scheduled
|
Aug 7
| ||
Form 4
| -5.67% | -20.00K |
$25.00 | -$500,000.00 | 333.01K |
Scheduled
|
Jun 4
| ||
Form 4
| +29.52% | 80.45K |
$21.00 | -$221,466.00 | 353.01K |
Mar 2
| |||
Form 4
| -6.54% | -19.09K |
$18.55 | -$354,026.75 | 272.56K |
May 8
| |||
Form 4
| +41.13% | 85K |
—
|
—
| 291.65K |
Feb 23
| |||
Form 4
| +6.06% | 11.81K |
$18.27 | $215,805.24 | 206.65K |
May 16
| |||
Form 4
| +8.84% | 17.74K |
$26.94 | -$492,041.90 | 218.46K |
Feb 26 - Mar 1
| |||
Form 4
| -0.99% | -2.00K |
$39.69 | -$79,380.00 | 200.72K |
Scheduled
|
Oct 1
| ||
Form 4
| -0.98% | -2.00K |
$61.19 | -$122,380.00 | 202.72K |
Scheduled
|
Sep 1
| ||
Form 4
| -0.97% | -2.00K |
$64.53 | -$129,060.00 | 204.72K |
Scheduled
|
Aug 3
| ||
Form 4
|
—
|
0
|
$44.00 | -$1,240,200.00 | 206.72K |
Scheduled
|
Jul 15
| ||
Form 4
| -0.96% | -2.00K |
$69.41 | -$138,820.00 | 206.72K |
Scheduled
|
Jul 1
| ||
Form 4
| -3.19% | -6.88K |
$41.45 | -$3,895,013.56 | 208.72K |
Scheduled
|
Jun 5
| ||
Form 4
| -5.01% | -11.38K |
$67.77 | -$771,087.06 | 215.6K |
Jun 2
| |||
Form 4
| -1.08% | -2.47K |
$49.70 | -$122,957.80 | 226.97K |
Mar 3
| |||
Form 4
| +15.04% | 30K |
—
|
—
| 229.45K |
Feb 26
| |||
Form 4
| -4.72% | -9.89K |
$40.49 | -$400,446.10 | 199.45K |
Dec 17
| |||
Form 4
| +23.62% | 40K |
—
|
—
| 209.34K |
Aug 19
| |||
Form 4
| +10.15% | 15.6K |
—
|
—
| 169.34K |
Feb 27
| |||
Form 4
| +6.96% | 10K |
$12.99 | $129,900.00 | 153.74K |
May 24
| |||
Form 4
| +32.44% | 16.84K |
$25.03 | -$204,294.86 | 68.74K |
May 14
| |||
Form 4
| +419.00% | 41.9K |
—
|
—
| 51.9K |
Feb 28
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
May 24 - May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MACROGENICS INC (MGNX) Snapshot price: $3.1701
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
∞
| 4.5K |
—
|
—
| 4.5K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GTC BIOTHERAPEUTICS INC No price found
Chairman, President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PRAECIS PHARMACEUTICALS INC No price found
President and COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +83.33% | 10K |
$3.58 | $35,800.00 | 22K |
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
| No matching records found | |||||||||